EXPLOITATION OF NOVEL PATHWAYS FOR ANTITUBERCULOSIS AGENTS

$148,800U19FY2000AINIH

National Jewish Health, Denver CO

Investigators

Linked publications & trials

Paper 18674969 Paper 12499218 Paper 12470715 Paper 11506156 Paper 11354664 Paper 11302803 Paper 11036043 Paper 10875802 Paper 10817693

View original record on NIH RePORTER →

EXPLOITATION OF NOVEL PATHWAYS FOR ANTITUBERCULOSIS AGENTS · GrantIndex